NCT03887052 - ASSURE WCD Clinical Evaluation - Detection and Safety Study | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

March 20, 2019

Primary Completion Date

June 18, 2019

Study Completion Date

June 18, 2019

Conditions

Cardiac Arrest, Sudden

Interventions

DEVICE

ASSURE™ Wearable Cardioverter Defibrillator (WCD)

WCD with shock alarms and shock functionality disabled

Trial Locations (10)

Washington Adventist Hospital, Takoma Park

Toledo ProMedica Hospital, Toledo

University of Michigan, Ann Arbor

Mayo Clinic, Rochester

Washington University St Louis, St Louis

Heart Clinic of Hammond, LA, Hammond

University of Washington Medical Center, Seattle

Institute for Research and Innovation MultiCare Health System, Tacoma

Alaska Cardiovascular Research Foundation, Anchorage

Cooper University Health Care, Camden